# Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation

> **NCT04237389** · NA · UNKNOWN · sponsor: **National Research Center of Surgery, Russia** · enrollment: 60 (estimated)

## Conditions studied

- Atrial Fibrillation, Persistent

## Interventions

- **PROCEDURE:** Ablation Index Guided endocardial catheter radiofrequency ablation
- **PROCEDURE:** minimally invasive thoracoscopic surgical epicardial ablation.

## Key facts

- **NCT ID:** NCT04237389
- **Lead sponsor:** National Research Center of Surgery, Russia
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-22
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04237389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04237389, "Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04237389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*